Spruce Biosciences

South San Francisco, United States

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

Apr 2026

Post-IPO Equity

Biopharma Biotechnology Health Care Pharmaceutical

Top Investors

Sands Capital VenturesNovo HoldingsAbingworthOmega FundsHealthCap

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Spruce Biosciences

Who are Spruce Biosciences's investors?

Spruce Biosciences's investors include Sands Capital Ventures, Novo Holdings, Abingworth, Omega Funds, HealthCap.

Where is Spruce Biosciences headquartered?

Spruce Biosciences is headquartered in South San Francisco, United States.

What does Spruce Biosciences do?

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

What stage is Spruce Biosciences at?

Spruce Biosciences is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 20, 2026.

MLA

"Spruce Biosciences — Funding & Investors." VCBacked, April 20, 2026, https://www.vcbacked.co/company/spruce-biosciences. Accessed June 7, 2026.

APA

VCBacked. (2026). Spruce Biosciences — Funding & Investors. Retrieved June 7, 2026, from https://www.vcbacked.co/company/spruce-biosciences

Wikipedia (cite web)

{{cite web |title=Spruce Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/spruce-biosciences |website=VCBacked |access-date=June 7, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 20, 2026.

Similar Companies in Biopharma